MedPharm, Moberg Derma, Zelmic AB deal

Moberg received an exclusive, worldwide license to use MedPharm's MedSpray sprayable drug delivery technology to develop and commercialize up to three undisclosed dermatology products. Moberg will combine the technology with its Kaprolac technology, which consists of dermatological compounds with antimicrobial, keratolytic and moisturizing properties. Financial terms were not disclosed. ...